-
1
-
-
3042743984
-
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation
-
DOI 10.1111/j.1600-6143.2004.00455.x
-
Kiberd BA, Lawen J, Fraser AD, Keough-Ryan T, Belitsky P Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. American Journal of Transplantation, 2004;4:1079-1083. (Pubitemid 38868597)
-
(2004)
American Journal of Transplantation
, vol.4
, Issue.7
, pp. 1079-1083
-
-
Kiberd, B.A.1
Lawen, J.2
Fraser, A.D.3
Keough-Ryan, T.4
Belitsky, P.5
-
2
-
-
0037743611
-
Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children
-
Filler G, Hansen M, LeBlanc C et al. Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatric Nephrology, 2003;18:445-449. (Pubitemid 36798488)
-
(2003)
Pediatric Nephrology
, vol.18
, Issue.5
, pp. 445-449
-
-
Filler, G.1
Hansen, M.2
LeBlanc, C.3
Lepage, N.4
Franke, D.5
Mai, I.6
Feber, J.7
-
3
-
-
0034869311
-
Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus
-
Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. The Journal of Rheumatology, 2001;28:2103-2108. (Pubitemid 32803791)
-
(2001)
Journal of Rheumatology
, vol.28
, Issue.9
, pp. 2103-2108
-
-
Buratti, S.1
Szer, I.S.2
Spencer, C.H.3
Bartosh, S.4
Reiff, A.5
-
4
-
-
0036051895
-
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents
-
Karim MY, Alba P, Cuadrado MJ et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford), 2002;41:876-882.
-
(2002)
Rheumatology (Oxford)
, vol.41
, pp. 876-882
-
-
Karim, M.Y.1
Alba, P.2
Cuadrado, M.J.3
-
5
-
-
0034788417
-
The safety and efficacy of MMF in lupus nephritis: A pilot study
-
DOI 10.1191/096120301682430186
-
Kingdon EJ, McLean AG, Psimenou E et al. The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus, 2001;10:606-611. (Pubitemid 32959274)
-
(2001)
Lupus
, vol.10
, Issue.9
, pp. 606-611
-
-
Kingdon, E.J.1
McLean, A.G.2
Psimenou, E.3
Davenport, A.4
Powis, S.H.5
Sweny, P.6
Burns, A.7
-
6
-
-
28144433147
-
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
-
DOI 10.1056/NEJMoa043731
-
Ginzler EM, Dooley MA, Aranow C et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. The New England Journal of Medicine, 2005;353:2219-2228. (Pubitemid 41697285)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.21
, pp. 2219-2228
-
-
Ginzler, E.M.1
Dooley, M.A.2
Aranow, C.3
Kim, M.Y.4
Buyon, J.5
Merrill, J.T.6
Petri, M.7
Gilkeson, G.S.8
Wallace, D.J.9
Weisman, M.H.10
Appel, G.B.11
-
7
-
-
1442355581
-
Sequential Therapies for Proliferative Lupus Nephritis
-
DOI 10.1056/NEJMoa031855
-
Contreras G, Pardo V, Leclercq B et al. Sequential therapies for proliferative lupus nephritis. The New England Journal of Medicine, 2004;350:971-980. (Pubitemid 38269274)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.10
, pp. 971-980
-
-
Contreras, G.1
Pardo, V.2
Leclercq, B.3
Lenz, O.4
Tozman, E.5
O'Nan, P.6
Roth, D.7
-
8
-
-
34948895412
-
Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: Mycophenolate mofetil or intravenous cyclophosphamide
-
DOI 10.1177/0961203307081340
-
Wang J, Hu W, Xie H et al. Induction therapies for class IV lupus nephritis with noninflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide. Lupus, 2007;16:707-712. (Pubitemid 47517865)
-
(2007)
Lupus
, vol.16
, Issue.9
, pp. 707-712
-
-
Wang, J.1
Hu, W.2
Xie, H.3
Zhang, H.4
Chen, H.5
Zeng, C.6
Liu, Z.7
Li, L.8
-
9
-
-
0031748776
-
Clinical pharmacokinetics of mycophenolate mofetil
-
DOI 10.2165/00003088-199834060-00002
-
Bullingham RE, Nicholls AJ, Kamm BR Clinical pharmacokinetics of mycophenolate mofetil. Clinical Pharmacokinetics, 1998;34:429-455. (Pubitemid 28273453)
-
(1998)
Clinical Pharmacokinetics
, vol.34
, Issue.6
, pp. 429-455
-
-
Bullingham, R.E.S.1
Nicholls, A.J.2
Kamm, B.R.3
-
10
-
-
0036191888
-
The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: A report of the German study group on mycophenolate mofetil therapy
-
Weber LT, Shipkova M, Armstrong VW et al. The pharmacokinetic- pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. Journal of the American Society of Nephrology, 2002;13:759-768. (Pubitemid 34183943)
-
(2002)
Journal of the American Society of Nephrology
, vol.13
, Issue.3
, pp. 759-768
-
-
Weber, L.T.1
Shipkova, M.2
Armstrong, V.W.3
Wagner, N.4
Schutz, E.5
Mehls, O.6
Zimmerhackl, L.B.7
Oellerich, M.8
Tonshoff, B.9
-
11
-
-
0034961129
-
Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation
-
Mourad M, Malaise J, Chaib Eddour D et al. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clinical Chemistry, 2001;47:1241-1248. (Pubitemid 32579112)
-
(2001)
Clinical Chemistry
, vol.47
, Issue.7
, pp. 1241-1248
-
-
Mourad, M.1
Malaise, J.2
Eddour, D.C.3
De Meyer, M.4
Konig, J.5
Schepers, R.6
Squifflet, J.P.7
Wallemacq, P.8
-
12
-
-
0037373072
-
Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients
-
DOI 10.1097/01.ASN.0000051598.12824.DA
-
Neumann I, Haidinger M, Jäger H et al. Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients. Journal of the American Society of Nephrology, 2003;14:721-727. (Pubitemid 36246016)
-
(2003)
Journal of the American Society of Nephrology
, vol.14
, Issue.3
, pp. 721-727
-
-
Neumann, I.1
Haidinger, M.2
Jager, H.3
Grutzmacher, H.4
Griesmacher, A.5
Muller, M.M.6
Bayer, P.M.7
Meisl, F.T.8
-
13
-
-
54149103127
-
Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil
-
Neumann I, Fuhrmann H, Fang IF, Jaeger A, Bayer P, Kovarik J Association between mycophenolic acid 12-h trough levels and clinical endpoints in patients with autoimmune disease on mycophenolate mofetil. Nephrology Dialysis Transplantation, 2008;23:3514-3520.
-
(2008)
Nephrology Dialysis Transplantation
, vol.23
, pp. 3514-3520
-
-
Neumann, I.1
Fuhrmann, H.2
Fang, I.F.3
Jaeger, A.4
Bayer, P.5
Kovarik, J.6
-
14
-
-
42649099997
-
Pharmacokinetics of enteric-coated mycophenolate sodium: Comparative study in patients with autoimmune disease and renal allograft
-
DOI 10.1517/14656566.9.6.879
-
Neumann I, Fuhrmann H, Kanzler M et al. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft. Expert Opinion on Pharmacotherapy, 2008;9:879-886. (Pubitemid 351593736)
-
(2008)
Expert Opinion on Pharmacotherapy
, vol.9
, Issue.6
, pp. 879-886
-
-
Neumann, I.1
Fuhrmann, H.2
Kanzler, M.3
Fang, I.-F.4
Jaeger, A.5
Graf, H.6
Bayer, P.7
Kovarik, J.8
-
15
-
-
57749086299
-
Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation
-
Mino Y, Naito T, Matsushita T et al. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation. Therapeutic Drug Monitoring, 2008;30:656-661.
-
(2008)
Therapeutic Drug Monitoring
, vol.30
, pp. 656-661
-
-
Mino, Y.1
Naito, T.2
Matsushita, T.3
-
16
-
-
40549127818
-
Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies
-
Zahr N, Amoura Z, Debord J et al. Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies. Clinical Pharmacokinetics, 2008;47:277-284. (Pubitemid 351367437)
-
(2008)
Clinical Pharmacokinetics
, vol.47
, Issue.4
, pp. 277-284
-
-
Zahr, N.1
Amoura, Z.2
Debord, J.3
Hulot, J.-S.4
Saint-Marcoux, F.5
Marquet, P.6
Piette, J.C.7
Lechat, P.8
-
17
-
-
59949088265
-
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis
-
Joy MS, Hilliard T, Hu Y et al. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy, 2009;29:7-16.
-
(2009)
Pharmacotherapy
, vol.29
, pp. 7-16
-
-
Joy, M.S.1
Hilliard, T.2
Hu, Y.3
-
18
-
-
34548051575
-
Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis
-
Czock D, Rasche FM, Carius A et al. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis. The Journal of Clinical Pharmacology, 2007;47:850-859.
-
(2007)
The Journal of Clinical Pharmacology
, vol.47
, pp. 850-859
-
-
Czock, D.1
Rasche, F.M.2
Carius, A.3
-
19
-
-
0029899127
-
Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid
-
DOI 10.1016/S0092-8674(00)81275-1
-
Sintchak MD, Fleming MA, Futer O et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell, 1996;85:921-930. (Pubitemid 26192142)
-
(1996)
Cell
, vol.85
, Issue.6
, pp. 921-930
-
-
Sintchak, M.D.1
Fleming, M.A.2
Futer, O.3
Raybuck, S.A.4
Chambers, S.P.5
Caron, P.R.6
Murcko, M.A.7
Wilson, K.P.8
-
20
-
-
57749117648
-
Pharmacodynamics of mycophenolic acid in CD4+ cells: A single-dose study of IMPDH and purine nucleotide responses in healthy individuals
-
Vethe NT, Bremer S, Rootwelt H, Bergan S Pharmacodynamics of mycophenolic acid in CD4+ cells: a single-dose study of IMPDH and purine nucleotide responses in healthy individuals. Therapeutic Drug Monitoring, 2008;30:647-655.
-
(2008)
Therapeutic Drug Monitoring
, vol.30
, pp. 647-655
-
-
Vethe, N.T.1
Bremer, S.2
Rootwelt, H.3
Bergan, S.4
-
21
-
-
33745957413
-
Therapeutic drug monitoring of mycophenolate mofetil in transplantation
-
DOI 10.1097/01.ftd.0000199358.80013.bd, PII 0000769120060400000001
-
van Gelder T, Le Meur Y, Shaw LM et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Therapeutic Drug Monitoring, 2006;28:145-154. (Pubitemid 44314941)
-
(2006)
Therapeutic Drug Monitoring
, vol.28
, Issue.2
, pp. 145-154
-
-
Van Gelder, T.1
Meur, Y.L.2
Shaw, L.M.3
Oellerich, M.4
DeNofrio, D.5
Holt, C.6
Holt, D.W.7
Kaplan, B.8
Kuypers, D.9
Meiser, B.10
Toenshoff, B.11
Mamelok, R.D.12
-
23
-
-
37749033876
-
Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography
-
Mino Y, Naito T, Matsushita T, Kagawa Y, Kawakami J Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, 2008;46:603-608.
-
(2008)
Journal of Pharmaceutical and Biomedical Analysis
, vol.46
, pp. 603-608
-
-
Mino, Y.1
Naito, T.2
Matsushita, T.3
Kagawa, Y.4
Kawakami, J.5
-
24
-
-
33746442024
-
Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus
-
Su DL, Wang HJ, Ji XH et al. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Acta Pharmacologica Sinica, 2006;27:1051-1057.
-
(2006)
Acta Pharmacologica Sinica
, vol.27
, pp. 1051-1057
-
-
Su, D.L.1
Wang, H.J.2
Ji, X.H.3
-
25
-
-
33746383697
-
The abnormal expression of IL-10, IFN-c, IP-10 and IL-12 in patients with systemic lupus erythematosus and the effects of cyclosporine A and cyclophosphamide on it
-
Jiang YZ, Ji XH, Ji YF, Su DL The abnormal expression of IL-10, IFN-c, IP-10 and IL-12 in patients with systemic lupus erythematosus and the effects of cyclosporine A and cyclophosphamide on it. Acta Universitatis Medicinalis Nanjing, 2005;25:633-636.
-
(2005)
Acta Universitatis Medicinalis Nanjing
, vol.25
, pp. 633-636
-
-
Jiang, Y.Z.1
Ji, X.H.2
Ji, Y.F.3
Su, D.L.4
-
26
-
-
0035043299
-
Treatment of lupus with corticosteroids
-
DOI 10.1191/096120301675075008
-
Chatham WW, Kimberly RP Treatment of lupus with corticosteroids. Lupus, 2001;10:140-147. (Pubitemid 32410067)
-
(2001)
Lupus
, vol.10
, Issue.3
, pp. 140-147
-
-
Chatham, W.W.1
Kimberly, R.P.2
-
27
-
-
0029058395
-
Mycophenolic acid binding to human serum albumin: Characterization and relation to pharmacodynamics
-
Nowak I, Shaw LM Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics. Clinical Chemistry, 1995;41:1011-1017.
-
(1995)
Clinical Chemistry
, vol.41
, pp. 1011-1017
-
-
Nowak, I.1
Shaw, L.M.2
-
28
-
-
2542590879
-
Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia
-
DOI 10.1097/00007691-200406000-00011
-
Atcheson BA, Taylor PJ, Kirkpatrick CM et al. Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 2004;26:284-286. (Pubitemid 38703015)
-
(2004)
Therapeutic Drug Monitoring
, vol.26
, Issue.3
, pp. 284-286
-
-
Atcheson, B.A.1
Taylor, P.J.2
Kirkpatrick, C.M.J.3
Duffull, S.B.4
Mudge, D.W.5
Pillans, P.I.6
Johnson, D.W.7
Tett, S.E.8
-
29
-
-
0344890150
-
Therapeutic drug monitoring of mycophenolic acid: Comparison of HPLC and immunoassay reveals new MPA metabolites
-
DOI 10.1016/S0041-1345(98)00201-2, PII S0041134598002012
-
Schütz E, Shipkova M, Armstrong VW et al. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplantation Proceedings, 1998;30:1185-1187. (Pubitemid 28309531)
-
(1998)
Transplantation Proceedings
, vol.30
, Issue.4
, pp. 1185-1187
-
-
Schutz, E.1
Shipkova, M.2
Armstrong, V.W.3
Niedmann, P.D.4
Weber, L.5
Tonshoff, B.6
Pethig, K.7
Wahlers, T.8
Braun, F.9
Ringe, B.10
Oellerich, M.11
-
30
-
-
33748184749
-
Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: Comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry
-
DOI 10.1097/01.ftd.0000197092.84935.ef, PII 0000769120060400000022
-
Prémaud A, Rousseau A, Picard N, Marquet P Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Therapeutic Drug Monitoring, 2006;28:274-277. (Pubitemid 44314962)
-
(2006)
Therapeutic Drug Monitoring
, vol.28
, Issue.2
, pp. 274-277
-
-
Premaud, A.1
Rousseau, A.2
Picard, N.3
Marquet, P.4
-
31
-
-
63649157074
-
Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients
-
Mino Y, Naito T, Otsuka A et al. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients. Clinical Biochemistry, 2009;42:595-601.
-
(2009)
Clinical Biochemistry
, vol.42
, pp. 595-601
-
-
Mino, Y.1
Naito, T.2
Otsuka, A.3
|